Cargando…
Radiation for persistent or recurrent epithelial ovarian cancer: a need for reassessment
PURPOSE: The role of radiotherapy (RT) was largely deserted after the introduction of platinum-based chemotherapy, but still survival rates are disappointingly low. This study focuses on assessing the clinical efficacy of RT in relation to chemotherapy resistance. MATERIALS AND METHODS: From October...
Autores principales: | Choi, Noorie, Chang, Ji Hyun, Kim, Suzy, Kim, Hak Jae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Radiation Oncology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518454/ https://www.ncbi.nlm.nih.gov/pubmed/28712280 http://dx.doi.org/10.3857/roj.2017.00213 |
Ejemplares similares
-
Radiation-Induced Sarcoma: A 15-Year Experience in a Single Large Tertiary Referral Center
por: Kim, Kyung Su, et al.
Publicado: (2016) -
Retrospective study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancer
por: Shin, Wonkyo, et al.
Publicado: (2018) -
The Need for Assessment and Reassessment of the Hospital Cancer Conference
por: Greene, Frederick L.
Publicado: (2009) -
Palliative Radiation Therapy for Metastatic, Persistent, or Recurrent Epithelial Ovarian Cancer: Efficacy in the Era of Modern Technology and Targeted Agents
por: Butala, Anish A., et al.
Publicado: (2020) -
Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer
por: Kang, Heeseok, et al.
Publicado: (2009)